Skip to main content
. Author manuscript; available in PMC: 2009 Apr 1.
Published in final edited form as: Neuropsychopharmacology. 2007 Jul 11;33(5):1049–1061. doi: 10.1038/sj.npp.1301498

Table 2.

Mean Concentrations E2, T, or 3α-diol in the Plasma of aged, Intact; Young, Intact; and Young, GDX Male Mice 1 h Following Administration of Vehicle or 1 mg/kg s.c. E2, T, or 3α-diol, 1 h before Testing

Condition E2 (pg/mg) T (ng/mg) 3α-diol (ng/mg)
Aged, intact mice
 Vehicle (n = 4) 0.4 ± 0.1 0.4 ± 0.1 0.4 ± 0.1
 E2 (n = 4) 2.0 ± 0.3* 0.5 ± 0.2 0.8 ± 0.2
 T(n = 4) 1.4 ± 0.3* 2.9 ± 1.7* 1.6 ± 0.2*
 3α-diol (n = 4) 0.5 ± 0.2 0.4 ± 0.04 2.5 ± 0.6*
Young, intact mice
 Vehicle (n = 5) 7.5 ± 3.0 2.7 ± 1.5 6.4 ± 5.0
 E2 (n = 5) 9.3 ± 1.2 1.8 ± 0.8 4.4 ± 2.3
 T(n = 5) 2.6 ± 1.7 5.1 ±1.7 2.6 ± 1.5
 3α-diol (n = 5) 5.6 ± 1.7 4.2 ±1.5 9.5 ± 3.3
Young. GDX mice
 Vehicle (n = 5) 0.8 ± 0.5 0.3 ± 0.4 0.3 ± 0.1
 E2(n = 5) 2.0 ± 0.7# 0.4 ± 0.3 0.2 ± 0.1
 T(n = 5) 2.8 ± 1.8# 0.3 ± 0.2 0.6 ± 0.1
 3α-diol (n = 5) 0.6 ± 0.3 0.3 ± 0.2 0.6 ±0.2
*

Denotes significant difference from vehicle (P < 0.05).

#

denotes tendency to be different from control (P <0.10).